Scott Lyle Rush

Address:

4744 NW 99 Ln, Coral Springs, FL 33076

Phone:

9542278950

VIN:

5FNRL38707B402078

Make:

HONDA

Model:

ODYSSEY

Year:

2007

US Patent:

6852122, Feb 8, 2005

Filed:

Jan 23, 2003

Appl. No.:

10/349776

Inventors:

Scott Lyle Rush - Coral Springs FL, US

Assignee:

Cordis Corporation - Miami Lakes FL

International Classification:

A61F002/06

US Classification:

623 113, 623 136

Abstract:

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned.

US Patent:

8083792, Dec 27, 2011

Filed:

Jan 24, 2006

Appl. No.:

11/338281

Inventors:

Donald D. Boucher - Boynton Beach FL, US
Michael Dugery - Doylestown PA, US
Kirk L. Johnson - Davie FL, US
Isaac John Khan - Bridgewater NJ, US
David C. Majercak - Stewartsville NJ, US
Scott Lyle Rush - Coral Springs FL, US

Assignee:

Cordis Corporation - Bridgewater NJ

International Classification:

A61F 2/06

US Classification:

623 135, 623 111, 623 116

Abstract:

An endoprosthetic device for treating abdominal aortic aneurysms using suprarenal fixation. A stent ring is anchored in an area above the renal arteries using self-flaring barbs that project during the nitinol expansion process. Sutures extend from the stent ring to an area below the renal arteries to a bifurcated trunk portion comprising a nitinol fabric on a non-kinking frame. The bifurcated trunk is sealed proximal the iliac arteries and includes iliac leg holders having self-flaring retention struts for non-traumatic holding of iliac leg prosthetics. Suprarenal fixation and collapsible cells having retention projections and barbs that only flare during the nitinol expansion process assist in lowering the devices profile and sheathability for percutaneous delivery and may provide for recapturing the anchored device.

US Patent:

20040167572, Aug 26, 2004

Filed:

Feb 20, 2003

Appl. No.:

10/371925

Inventors:

Noah Roth - Highland Park NJ, US
Scott Rush - Coral Springs FL, US
Theresa Scheuble - Rockaway NJ, US

International Classification:

A61B017/08

US Classification:

606/219000, 604/265000, 427/002100

Abstract:

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples.

US Patent:

20050137677, Jun 23, 2005

Filed:

Dec 17, 2003

Appl. No.:

10/737983

Inventors:

Scott Rush - Coral Springs FL, US

International Classification:

A61F002/06

US Classification:

623001130

Abstract:

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device such as a stent-graft. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. A stent-graft fabricated from a thin-walled, high strength material provides for a more durable and lower profile endoprosthesis. The stent-graft comprises one or more stent segments covered with a fabric formed by the weaving, knitting or braiding of a biocompatible, high tensile strength, abrasion resistant, highly durable yarn such as ultra high molecular weight polyethylene. The one or more stent segments may be balloon expandable or self-expanding. The fabric may be attached to the stent segments utilizing any number of known materials and techniques. In addition, the pore size of the graft material may be varied.

US Patent:

20100030255, Feb 4, 2010

Filed:

Jun 30, 2009

Appl. No.:

12/459387

Inventors:

Humberto Berra - Cooper City FL, US
Bryan White - Weston FL, US
Timothy Lostetter - Pembroke Pines FL, US
Scott Lyle Rush - Coral Springs FL, US
John C. Canning - Boynton Beach FL, US

International Classification:

A61F 2/01
A61F 2/06

US Classification:

606200, 623 113, 623 111

Abstract:

Delivery systems, components of delivery system, stent graft systems, stent graft delivery systems can be used to treat aortic aneurysms.

US Patent:

20120059452, Mar 8, 2012

Filed:

Nov 14, 2011

Appl. No.:

13/295213

Inventors:

Donald D. Boucher - Boynton Beach FL, US
Michael Dugery - Doylestown PA, US
Kirk L. Johnson - Davie FL, US
Issac John Khan - Bridgewater NJ, US
David C. Majercak - Stewartsville NJ, US
Scott Lyle Rush - Coral Springs FL, US

International Classification:

A61F 2/82

US Classification:

623 115, 623 135

Abstract:

An endoprosthetic device for treating abdominal aortic aneurysms using suprarenal fixation. A stent ring is anchored in an area above the renal arties using self-flaring barbs that project during the nitinol expansion process. Sutures extend from the stent ring to an area below the renal arties to a bifurcated trunk portion comprising a nitinol fabric on a non-kinking frame. The bifurcated trunk is sealed proximal the iliac arteries and includes iliac leg holders having self-flaring retention struts for non-traumatic holding of iliac leg prosthetics. Suprarenal fixation and collapsible cells having retention projections and barbs that only flare during the nitinol expansion process assist in lowering the devices profile and sheathability for percutaneous delivery and may provide for recapturing the anchored device.

US Patent:

20220313464, Oct 6, 2022

Filed:

Jun 21, 2022

Appl. No.:

17/845530

Inventors:

- Sunrise FL, US
Nico Bahar - Sunrise FL, US
Eduardo Alejandro Garcia - Sunrise FL, US
Scott L. Rush - Sunrise FL, US

International Classification:

A61F 2/966

Abstract:

A delivery system and method for implanting a stent graft prostheses includes and employs a torque component at a distal end of the stent graft prosthesis, whereby following advancement of the stent graft to a surgical site in a constrained or partially constrained configuration, torque is applied to the torque component and, consequently, to the stent graft to rotationally align the stent graft about a longitudinal axis of the stent graft, followed by deployment of the stent graft in correct rotational alignment, and subsequent retraction of the delivery device from the deployed stent graft and the subject. The torque component includes a pushrod and at least two arms.

US Patent:

20210307895, Oct 7, 2021

Filed:

Jun 22, 2021

Appl. No.:

17/354501

Inventors:

- Sunrise FL, US
Samuel Arbefeuille - Sunrise FL, US
John C. Canning - Sunrise FL, US
Fletcher Christian - Sunrise FL, US
Scott Lyle Rush - Sunrise FL, US
Bryan White - Sunrise FL, US
Eduardo Alejandro Garcia - Sunrise FL, US

International Classification:

A61F 2/07
A61F 2/848
A61F 2/89

Abstract:

A vascular repair device assembly includes a main prostheses, first internal prostheses, an optional second internal prostheses, and at least two sub-prostheses. Methods for delivering vascular repair devices include delivering a vascular repair device through a blood vessel to the aneurysm site, aligning a proximal open end of a main prosthesis cranially to the site of the aneurysm patient and directing a distal end of at least one additional one vascular repair device through a proximal end of at least a first internal lumen, and aligning the proximal end of the additional vascular repair device into a distal end of the at least one sub-prosthesis.